Literature DB >> 12042274

Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome.

M Fawzy1, A Lambert, R F Harrison, P G Knight, N Groome, B Hennelly, W R Robertson.   

Abstract

BACKGROUND: Day 5 serum inhibin B during IVF treatment has been investigated as a predictor of outcome.
METHODS: A total of 54 women (< or = 39 years, normal menses and endocrine profiles) were treated with urinary gonadotrophins or recombinant FSH following pituitary down-regulation. Serum day 3 FSH in a preceding cycle was <8.5 IU/l. Plasma inhibin B, inhibin A and estradiol were determined after 4 days of gonadotrophin administration (day 5).
RESULTS: Day 5 inhibin B was the most highly correlated with the number of mature follicles (>14 mm), oocytes retrieved and fertilized. Receiver operating characteristic analysis gave high accuracy for day 5 inhibin B in predicting ovarian response and indicated that a threshold of 400 pg/ml may be helpful in the decision as to whether to continue treatment. Women with <400 pg/ml (n = 16) had lower numbers of follicles, mature follicles, oocytes retrieved, fertilized and cleaved compared with those >400 pg/ml (n = 36) and this threshold gave a positive likelihood ratio of 30, 92.9% sensitivity, 95.0% specificity and 86.7% positive predictive value to detect poor ovarian response. Day 5 inhibin B was the best predictor of pregnancy (no live births and four cycles cancelled, low inhibin group; nine live births and no cancelled cycles, high inhibin group).
CONCLUSIONS: Normogonadotrophic, normogonadal women with day 5 inhibin B <400 pg/ml in down-regulated cycles have a poor response to ovarian stimulation and are less likely to conceive compared with women with higher day 5 inhibin B.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042274     DOI: 10.1093/humrep/17.6.1535

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

1.  Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.

Authors:  Barbara Sonntag; Ludwig Kiesel; Eberhard Nieschlag; Hermann M Behre
Journal:  J Assist Reprod Genet       Date:  2004-07       Impact factor: 3.412

2.  Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.

Authors:  Fan Zhang; Xiao-Ling Liu; Nan Rong; Xiao-Wen Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-02-22

3.  Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF).

Authors:  D J Hendriks; E R Klinkert; L F J M M Bancsi; C W N Looman; J D F Habbema; E R te Velde; F J Broekmans
Journal:  J Assist Reprod Genet       Date:  2004-03       Impact factor: 3.412

4.  Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of Ovarian Hyperstimulation Syndrome in IVF patients.

Authors:  Jiri Moos; Karel Rezabek; Vanda Filova; Martina Moosova; Jana Pavelkova; Jana Peknicova
Journal:  Reprod Biol Endocrinol       Date:  2009-08-24       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.